Ozempic

Ozempic

Interactive Data Dashboards

Track the HIV & TB response

Key indicators, province breakdowns and downloadable graphs.

  • What breakthrough weight loss meds might mean for people with HIV

    In part 3 of a Spotlight special series on the role of new weight loss medicines like Ozempic in South Africa, we ask what these breakthrough jabs might mean for people living with HIV in the country. There is some tantalising early research on potential benefits, but also many uncertainties. Catherine Tomlinson reports.

    ·

  • Obesity medicines are needed in SA’s public sector. Can our government provide them?

    In South Africa, access to weight loss medicines like Ozempic and Mounjaro remains limited to those who can shell out a few thousand Rand a month. In the second article of a Spotlight special series, Catherine Tomlinson looks at the medical need for these medicines in the country and what it would take for government…

    ·

  • Blockbuster weight-loss and diabetes medicines sales surge despite cost barriers

    Sales of weight loss medicines like Ozempic and Mounjaro have sky-rocketed in South Africa in recent years, although they remain too expensive for most people who might benefit from the jabs. In the first article of this Spotlight special series, Catherine Tomlinson tracks their remarkable rise and assesses when they will become more widely available…

    ·

  • The way we understand obesity is changing: What does it mean for South Africa?

    Health workers have long relied on Body Mass Index (BMI) as a way to measure whether people are within a healthy weight range. Now, a collection of top researchers have made the case for a new way to understand and diagnose obesity. In part two of this special Spotlight series, we take a look at…

    ·

  • Which of the breakthrough weight loss medicines can you get in SA?

    The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, access to these medicines remain limited in South Africa. Catherine Tomlinson asks which of the GLP-1 agonists are available here and at what…

    ·

  • “There is so much to be done,” says founder of SA’s largest online diabetes community

    As a type 1 diabetic, first diagnosed only days away from slipping into a hyperglycaemic coma, diabetes education is close to Bridget McNulty’s heart. Biénne Huisman chatted to McNulty about living with the condition, starting South Africa’s largest online diabetes community, and what can be done to improve diabetes education in South Africa.

    ·

  • Taking a spoon to a knife fight – Is SA ready for rising obesity rates?

    Experts describe rising obesity rates in South Africa as an “urgent crisis”, “a tsunami” – even an “epidemic” – that is costing lives, not to mention billions of rands. Tackling the situation warrants an action plan that is as comprehensive and cogent as the problem is dire. But does the new national strategy fit the…

    ·

  • SA’s obesity problem and the promise of new weight loss medicines

    Obesity is a complicated public health issue that can be devastating on both the societal and the individual level. New weight loss medicines have shown remarkable efficacy in clinical trials, but their high cost is limiting uptake. Amy Green asks where these new medicines should fit into South Africa’s response to rising levels of obesity.

    ·